Saurus, P
Kuusela, S
Lehtonen, E http://orcid.org/0000-0003-4189-2415
Hyvönen, M E
Ristola, M
Fogarty, C L
Tienari, J
Lassenius, M I
Forsblom, C
Lehto, M
Saleem, M A
Groop, P-H
Holthöfer, H
Lehtonen, S
Article History
Received: 19 November 2014
Revised: 30 March 2015
Accepted: 31 March 2015
First Online: 7 May 2015
Competing interests
: P-HG has received lecture honoraria from Abbot, Boehringer Ingelheim, Cebix, Eli Lilly, Genzyme, Novartis, Novo Nordisk, and MSD, and research grants from Eli Lilly and Roche. P-HG is an advisory board member for Boehringer Ingelheim, Novartis, and Medscape.